Intrarenal vascular resistance parameters in kidney transplant patients receiving calcineurin inhibitor-based or sirolimus-based regimens

被引:6
|
作者
Lee, Po-Chu [1 ]
Lee, Chih-Yuan
Hu, Rey-Heng
Lo, Chiao [1 ]
Tsai, Meng-Kun [1 ]
Lee, Po-Huang
机构
[1] Natl Taiwan Univ Hosp, Dept Gen Surg, Yun Lin Branch, Taipei, Yun Lin County, Taiwan
关键词
calcineurin inhibitor; color Doppler ultrasonography; immunosuppressive agents; kidney transplantation; sirolimus; ALLOGRAFT DYSFUNCTION; CYCLOSPORINE-A; INDEXES; EFFICACY;
D O I
10.1093/ndt/gfp716
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Methods. Forty-nine renal transplant patients who received ultrasonography examination between January 2007 and December 2007 were enrolled in this case-control study. Thirty-one subjects received a CNI-based regimen, and 18 received a CNI-free (sirolimus-based) regimen. RI and PI were determined by duplex Doppler ultrasonography. Results. Patients receiving a CNI displayed lower cholesterol and triglyceride values and higher RI (mean: 0.7 vs. 0.6, P = 0.002) and PI values (mean: 1.3 vs. 1.1, P = 0.034). Multivariate analyses revealed that advanced age and use of alpha-blockers or diuretics were modestly associated with higher RI and PI values. By multivariate analysis, use of sirolimus was associated with a lower RI by -0.05 [95% confidence interval (CI): -0.085, -0.019; P = 0.003] but not with a lower PI (95% CI: -0.245, 0.001; P = 0.053). Conclusions. Use of sirolimus is only modestly correlated with a reduced RI and is not associated with a reduced PI. These observations question the superiority of CNI-free over CNI-based regimens with regard to reduction of intrarenal vascular resistance post-transplantation. These findings combined with those regarding recipient factors also cast doubt on the specificity of intrarenal resistance indices for predicting allograft function and/or survival.
引用
收藏
页码:1675 / 1680
页数:6
相关论文
共 50 条
  • [1] Rates of cellular and antibody mediated rejection among patients with sirolimus-based versus calcineurin inhibitor-based therapy.
    Miller, Dylan V.
    Roden, Anja C.
    Edwards, Brooks S.
    Rodeheffer, Richard J.
    Frantz, Robert P.
    Clavell, Alfredo L.
    Pereira, Naveen L.
    Daly, Richard C.
    McGregor, Christopher G. A.
    Raichlin, Eugenia
    Kushwaha, Sudhir S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 347 - 347
  • [2] Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation
    Lo, A
    Egidi, MF
    Gaber, LW
    Amiri, HS
    Vera, S
    Nezakatgoo, N
    Gaber, AS
    [J]. TRANSPLANTATION, 2004, 77 (08) : 1228 - 1235
  • [3] Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction
    Ruiz, Juan Carlos
    Campistol, Josep M.
    Sanchez-Fructuoso, Ana
    Rivera, Constantino
    Oliver, Juan
    Ramos, David
    Campos, Begona
    Arias, Manuel
    Diekmann, Fritz
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (11) : 3252 - 3257
  • [4] Sirolimus-based, calcineurin inhibitor-free regimen in kidney transplant patients: An open-label, randomized, controlled trial
    El-Agroudy, Amgad E.
    Al Arrayed, Sameer M.
    Al-Ghareeb, Sumaya M.
    Farid, Eman
    Alhelow, Hamad
    Abdulla, Sadiq
    [J]. EUROPEAN JOURNAL OF GENERAL MEDICINE, 2016, 13 (03): : 16 - 22
  • [5] Effect of Converting From Calcineurin Inhibitor- to Sirolimus-Based Immunosuppressant Regimen on Breast Fibroadenoma Among Kidney Transplant Patients
    Kim, Min Ji
    Kim, Byeong Woo
    Yoon, Young Chul
    Seo, Won Ik
    Park, Young Mi
    Kang, Sun Woo
    Kim, Tae Hee
    Kim, Yeong Hoon
    [J]. TRANSPLANTATION PROCEEDINGS, 2019, 51 (06) : 1848 - 1852
  • [6] Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation
    Stephany, Brian R.
    Augustine, Joshua J.
    Krishnamurthi, Venkatesh
    Goldfarb, David A.
    Flechner, Stuart M.
    Braun, William E.
    Hricik, Donald E.
    Dennis, Vincent W.
    Poggio, Emilio D.
    [J]. TRANSPLANTATION, 2006, 82 (03) : 368 - 374
  • [7] Calcineurin-Inhibitor Free Sirolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients
    Rossano, Joseph W.
    Ryan, Rachel M.
    Orfanelli, Laura
    McCandless, Karen V.
    Kaufman, Beth D.
    Lin, Kimberly Y.
    Paridon, Stephen M.
    Hanna, Brian D.
    Shaddy, Robert E.
    [J]. CIRCULATION, 2012, 126 (21)
  • [8] Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience
    Alarrayed, Sameer M.
    El-Agroudy, Amgad E.
    Alarrayed, Ahmad S.
    Al Ghareeb, Sumaya M.
    Garadah, Taysir S.
    El-Sharqawi, Salah Y.
    Al-Aradi, Ali H.
    Dandi, Balaji G.
    Abdulla, Sadiq
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (03) : 248 - 255
  • [9] Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience
    Sameer M. Alarrayed
    Amgad E. El-Agroudy
    Ahmad S. Alarrayed
    Sumaya M. Al Ghareeb
    Taysir S. Garadah
    Salah Y. El-Sharqawi
    Ali H. Al-Aradi
    Balaji G. Dandi
    Sadiq Abdulla
    [J]. Clinical and Experimental Nephrology, 2010, 14 : 248 - 255
  • [10] IMPROVEMENT IN GLUCOSE REGULATION AND VASCULAR FUNCTION IN RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN-INHIBITOR TO SIROLIMUS-BASED IMMUNOSUPPRESSION
    Messineo, A.
    Viecelli, A.
    Chan, D.
    Dogra, G.
    Lim, W.
    [J]. NEPHROLOGY, 2010, 15 : 60 - 61